Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-25

FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved the preservative-free fixed-dose combination of dorzolamide hydrochloride and timolol maleate under Micro Labs Limited's original application. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride and timolol maleate (preservative-free) (Dorzolamide hydrochloride and timolol maleate preservative-free)

Snippet

ORIG AP for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE)